Sanomedics International Holdings, Inc., announced today that demand is soaring for its Caregiver® TouchFree™ Clinical Thermometers, primed by the growing concern for spread of EBOLA and MERS infections. The Company is gearing up for heavy inventory requirements to support this global effort at all healthcare facilities and ports-of-entry.
Keith Houlihan, President of Sanomedics, noted that multiple shipments have been made in recent days to the Centers for Disease Control ("CDC") in Atlanta as well as to other enterprise customers for use in corporate healthcare centers. He went on to indicate that the Company will focus on assisting all segments of the CDC, National Institutes of Health, Department of Homeland Security, and general healthcare facility efforts to reduce the risk of contact/spread of these diseases.
Thermomedics' Vice President of Marketing and Sales, Ron Benincasa, explained that the Caregiver reads only naturally emitted infrared radiation from the subject's body and does NOT employ any "laser" energy as has recently been noted in reports about other, non-clinical grade devices. It is completely safe and clinically proven to be accurate for all ages.
About Sanomedics International Holdings, Inc.
Sanomedics International Holdings, Inc. (OTCQB:SIMH) is a medical technology holding company that focuses on game changing products, services and ideas -- a place where physicians, entrepreneurs, and medical companies can work together to drive innovative technologies through concept, development, and ultimately commercialization. Sanomedics plans to grow existing business organically and through strategic acquisitions specifically relating to healthcare technology and services.
Sign up for Sanomedics email news alert system today at: http://ir.stockpr.com/sanomedics/email-alerts.
Follow Sanomedics on Twitter https://twitter.com/sanomedics and tweet us (@Sanomedics) your questions and comments. We would love to hear from you!